plicamycin has been researched along with vorinostat in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Becker, JC; Fan, K; Nghiem, P; Paulson, KG; Ritter, C; Schrama, D | 1 |
1 other study(ies) available for plicamycin and vorinostat
Article | Year |
---|---|
Reversal of epigenetic silencing of MHC class I chain-related protein A and B improves immune recognition of Merkel cell carcinoma.
Topics: Acetylation; Animals; Carcinoma, Merkel Cell; Cell Line, Tumor; Cytotoxicity, Immunologic; Gene Silencing; Histocompatibility Antigens Class I; Histone Deacetylase Inhibitors; Histone Deacetylases; Histones; Humans; Hydroxamic Acids; Killer Cells, Lymphokine-Activated; Mice; Mice, Inbred NOD; NK Cell Lectin-Like Receptor Subfamily K; Plicamycin; Promoter Regions, Genetic; Signal Transduction; Skin Neoplasms; Vorinostat; Xenograft Model Antitumor Assays | 2016 |